These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15609351)

  • 1. Binding of recombinant PrPc to human plasminogen: kinetic and thermodynamic study using a resonant mirror biosensor.
    Cuccioloni M; Amici M; Eleuteri AM; Biagetti M; Barocci S; Angeletti M
    Proteins; 2005 Feb; 58(3):728-34. PubMed ID: 15609351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of disease-associated prion protein to plasminogen.
    Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
    Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the interaction between prion protein and nucleic acid.
    Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
    Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of possible prion protein self-interaction domains using peptide arrays.
    Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
    BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
    Touil F; Pratt S; Mutter R; Chen B
    J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of proteins with high affinity for refolded and native PrPC.
    Petrakis S; Sklaviadis T
    Proteomics; 2006 Dec; 6(24):6476-84. PubMed ID: 17111435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein.
    Schmitt-Ulms G; Legname G; Baldwin MA; Ball HL; Bradon N; Bosque PJ; Crossin KL; Edelman GM; DeArmond SJ; Cohen FE; Prusiner SB
    J Mol Biol; 2001 Dec; 314(5):1209-25. PubMed ID: 11743735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous deamidation and isomerization of Asn108 in prion peptide 106-126 and in full-length prion protein.
    Sandmeier E; Hunziker P; Kunz B; Sack R; Christen P
    Biochem Biophys Res Commun; 1999 Aug; 261(3):578-83. PubMed ID: 10441469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
    Breydo L; Bocharova OV; Baskakov IV
    Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
    Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
    Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
    Triantaphyllidou IE; Sklaviadis T; Vynios DH
    Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the osmolyte trimethylamine N-oxide on the stability of the prion protein at low pH.
    Granata V; Palladino P; Tizzano B; Negro A; Berisio R; Zagari A
    Biopolymers; 2006 Jun; 82(3):234-40. PubMed ID: 16489585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
    Hesp JR; Raven ND; Sutton JM
    Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
    Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered prion protein glycosylation in the aging mouse brain.
    Goh AX; Li C; Sy MS; Wong BS
    J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse.
    Kuczius T; Grassi J; Karch H; Groschup MH
    FEBS J; 2007 Mar; 274(6):1492-502. PubMed ID: 17302739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
    Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
    Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.